Perspectives on percutaneous penetration of nanomaterials

Nanotechnology in Dermatology

Volumn , Issue , 2013, Pages 63-86

  Ngo, Mai A ^a   O'Malley, Michael ^b   Maibach, Howard I ^c  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH RISKS; NANOPARTICLES; RISK ASSESSMENT; UNCERTAINTY ANALYSIS;

CONTROLLED TESTS; DERMAL EXPOSURE; DYNAMIC PROCESS; LOCALISED; NANOSCALE MATERIAL; PERCUTANEOUS ABSORPTION; PERCUTANEOUS PENETRATION; POTENTIAL RISKS; TEN STEPS; UNCERTAINTY;

NANOSTRUCTURED MATERIALS;

EID: 84949178423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5034-4_7     Document Type: Chapter

References (174)

1. ISO TS 27687:2008 -Nanotechnologies -Terminology and definitions for nano-objects-Nanoparticle, nanofibre and nanoplate.
2. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159-64.
3. Mahe B, Vogt A, Liard C, Duffy D, Abadie V, Bonduelle O, et al. Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol. 2009;129(5):1156-64.
4. Jung S, Patzelt A, Otberg N, Thiede G, Sterry W, Lademann J. Strategy of topical vaccination with nanoparticles. J Biomed Opt. 2009;14(2):021001.
5. Wester RC, Maibach HI. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab Rev. 1983;14(2):169-205.
6. Farahmand S, Maibach HI. Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach. Int J Pharm. 2009;375(1-2):41-7.
7. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-9.
8. Patel H, ten Berge W, Cronin MT. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere. 2002;48(6):603-13.
9. Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9(5):663-9.
10. Scheuplein RJ, Blank IH. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol. 1973;60(5):286-96.
11. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48(1):79-88.
12. Thurn KT, Brown E, Wu A, Vogt S, Lai B, Maser J, et al. Nanoparticles for applications in cellular imaging. Nanoscale Res Lett. 2007;2(9):430-41.
13. Matilainen A, Sillanpaa M. Removal of natural organic matter from drinking water by advanced oxidation processes. Chemosphere. 2010;80(4):351-65.
14. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and in flammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci. 2006;92(1):174-85.
15. Lipovsky A, Gedanken A, Nitzan Y, Lubart R. Enhanced inactivation of bacteria by metal-oxide nanoparticles combined with visible light irradiation. Lasers Surg Med. 2011;43(3):236-40.
16. Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinology. 2009;1(4):197-206.
17. Labouta HI, el-Khordagui LK, Kraus T, Schneider M. Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale. 2011;3(12):4989-99.
18. Lademann J, Richter H, Schanzer S, Knorr F, Meinke M, Sterry W, et al. Penetration and storage of particles in human skin: perspectives and safety aspects. Eur J Pharm Biopharm. 2011;77(3):465-8.
19. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, Gabrielsson S, et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol. 2011;253(2):81-93.
20. Patzelt A, Richter H, Knorr F, Schafer U, Lehr CM, Dahne L, et al. Selective follicular targeting by modification of the particle sizes. J Control Release. 2011;150(1):45-8.
21. Lademann J, Patzelt A, Richter H, Antoniou C, Sterry W, Knorr F. Determination of the cuticula thickness of human and porcine hairs and their potential in fluence on the penetration of nanoparticles into the hair follicles. J Biomed Opt. 2009;14(2):021014.
22. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123(1):168-76.
23. Wu X, Landfester K, Musyanovych A, Guy RH. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol. 2010;23(3):117-23.
24. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci. 2006;91(1):159-65.
25. Scheuplein RJ, Blank IH, Brauner GJ, MacFarlane DJ. Percutaneous absorption of steroids. J Invest Dermatol. 1969;52(1):63-70.
26. Hadgraft J, Valenta C. pH, pK(a) and dermal delivery. Int J Pharm. 2000;200(2):243-7.
27. Gilpin SJ, Hui X, Maibach HI. Volatility of fragrance chemicals: patch testing implications. Dermatitis. 2009;20(4):200-7.
28. Farrell KA. Synthesis effects of grain size and phase content in the anastase-rutile TiO2 system. Thesis, Worcester Polytechnic Institute. 2001. www.wpi. edu/Pubs/ETD/Available/etd-081699-142023 .
29. Simpson CA, Agrawal AC, Balinski A, Harkness KM, Cliffel DE. Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts. ACS Nano. 2011;5(5):3577-84.
30. Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. 2nd ed. Boca Raton: CRC Press; 2006.
31. Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol. 2007;37(3):251-77.
32. Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RH, Sterry W, et al. Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm. 2007;67(3):699-706.
33. Neubert RH. Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm. 2011;77(1):1-2.
34. Schroeter A, Engelbrecht T, Neubert RH, Goebel AS. New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol. 2010;6(5):511-28.
35. Moody RP, Wester RC, Melendres JL, Maibach HI. Dermal absorption of the phenoxy herbicide 2,4-D dimethylamine in humans: effect of DEET and anatomic site. J Toxicol Environ Health. 1992;36(3):241-50.
36. Kuo TR, Wu CL, Hsu CT, Lo W, Chiang SJ, Lin SJ, et al. Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials. 2009;30(16):3002-8.
37. Xia XR, Monteiro-Riviere NA, Riviere JE. Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol. 2010;242(1):29-37.
38. Lee J, Yamakoshi Y, Hughes JB, Kim JH. Mechanism of C60 photoreactivity in water: fate of triplet state and radical anion and production of reactive oxygen species. Environ Sci Technol. 2008;42(9):3459-64.
39. Trommer H, Neubert RH. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol. 2006;19(2): 106-21.
40. Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A, et al. Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol. 2011;24(3):144-50.
41. Vieille-Petit A, Pirot F, Maibach HI. Lateral spreading from skin exposure: assessment with tape stripping. Submitted for publication.
42. Wester RC, Noonan PK, Maibach HI. Variations in percutaneous absorption of testosterone in the rhesus monkey due to anatomic site of application and frequency of application. Arch Dermatol Res. 1980;267(3):229-35.
43. Wester RC, Noonan PK, Maibach HI. Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol. 1977;113(5):620-2.
44. Rougier A, Lotte C, Maibach HI. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J Pharm Sci. 1987;76(6):451-4.
45. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122(1):14-9.
46. Ngo MA, O'Malley M, Maibach HI. Percutaneous absorption and exposure assessment of pesticides. J Appl Toxicol. 2009;30(2):91-114.
47. Vogt A, Mandt N, Lademann J, Schaefer H, Blume-Peytavi U. Follicular targeting-A promising tool in selective dermatotherapy. J Investig Dermatol Symp Proc. 2005;10(3):252-5.
48. Ohyama M. Hair follicle bulge: a fascinating reservoir of epithelial stem cells. J Dermatol Sci. 2007;46(2):81-9.
49. Blank IH, Scheuplein RJ. Transport into and within the skin. Br J Dermatol. 1969;81 Suppl 4:4-10.
50. Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 1967;48(2):181-3.
51. Maibach HI, Feldman RJ, Milby TH, Serat WF. Regional variation in percutaneous penetration in man. Arch Environ Health. 1971;23(3):208-11.
52. Kao J, Hall J, Helman G. In vitro percutaneous absorption in mouse skin: in fluence of skin appendages. Toxicol Appl Pharmacol. 1988;94(1):93-103.
53. Hueber F, Schaefer H, Wepierre J. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacol. 1994;7(5):237-44.
54. Jacobi U, Engel K, Patzelt A, Worm M, Sterry W, Lademann J. Penetration of pollen proteins into the skin. Skin Pharmacol Physiol. 2007;20(6):297-304.
55. Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, et al. Hair follicles-A long-term reservoir for drug delivery. Skin Pharmacol Physiol. 2006;19(4):232-6.
56. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol. 1999;12(5):247-56.
57. Gulson B, McCall M, Korsch M, Gomez L, Casey P, Oytam Y, et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci. 2010;118(1):140-9.
58. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126(6):1316-22.
59. Lademann J, Otberg N, Richter H, Weigmann HJ, Lindemann U, Schaefer H, et al. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:17-22.
60. Otberg N, Richter H, Knuttel A, Schaefer H, Sterry W, Lademann J. Laser spectroscopic methods for the characterization of open and closed follicles. Laser Phys Lett. 2004;1(1):46-9.
61. Teichmann A, Ossadnik M, Richter H, Sterry W, Lademann J. Semiquantitative determination of the penetration of a fluorescent hydrogel formulation into the hair follicle with and without follicular closure by microparticles by means of differential stripping. Skin Pharmacol Physiol. 2006;19(2): 101-5.
62. Mills PC, Magnusson BM, Cross SE. Investigation of in vitro transdermal absorption of fentanyl from patches placed on skin samples obtained from various anatomic regions of dogs. Am J Vet Res. 2004;65(12):1697-700.
63. Wester RC, Maibach HI. In vivo percutaneous absorption and decontamination of pesticides in humans. J Toxicol Environ Health. 1985;16(1):25-37.
64. Hoath SB, Maibach HI, editors. Neonatal skin: structure and function. 2nd ed. New York: Marcel Dekker; 2003.
65. Farage M, Maibach HI. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures. Contact Dermatitis. 2004;51(4):201-9.
66. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003;111(9): 1202-8.
67. Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro-Riviere NA. Effects of mechanical flexion on the penetration of fullerene amino acidderivatized peptide nanoparticles through skin. Nano Lett. 2007;7(1):155-60.
68. Mangelsdorf S, Otberg N, Maibach HI, Sinkgraven R, Sterry W, Lademann J. Ethnic variation in vellus hair follicle size and distribution. Skin Pharmacol Physiol. 2006;19(3):159-67.
69. Reinertson RP, Wheatley VR. Studies on the chemical composition of human epidermal lipids. J Invest Dermatol. 1959;32(1):49-59.
70. Wesley NO, Maibach HI. Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol. 2003;4(12):843-60.
71. Weigand DA, Haygood C, Gaylor JR. Cell layers and density of Negro and Caucasian stratum corneum. J Invest Dermatol. 1974;62(6):563-8.
72. Visscher MO, Chatterjee R, Munson KA, Pickens WL, Hoath SB. Changes in diapered and nondiapered infant skin over thefirst month of life. Pediatr Dermatol. 2000;17(1):45-51.
73. Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7): 1728-36.
74. Yosipovitch G, Maayan-Metzger A, Merlob P, Sirota L. Skin barrier properties in different body areas in neonates. Pediatrics. 2000;106(1 Pt 1):105-8.
75. Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26(4):343-57.
76. Farage MA, Miller KW, Maibach HI, editors. Textbook of aging skin. 2nd ed. Heidelberg: Springer; 2010.
77. Roskos KV, Maibach HI. Percutaneous absorption and age. Implications for therapy. Drugs Aging. 1992;2(5):432-49.
78. Meuling WJ, Franssen AC, Brouwer DH, van Hemmen JJ. The in fluence of skin moisture on the dermal absorption of propoxur in human volunteers: a consideration for biological monitoring practices. Sci Total Environ. 1997;199(1-2):165-72.
79. Williams RL, Aston LS, Krieger RI. Perspiration increased human pesticide absorption following surface contact during an indoor scripted activity program. J Expo Anal Environ Epidemiol. 2004;14(2):129-36.
80. Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol. 2001;14(1):1-10.
81. Treffel P, Muret P, Muret-D'Aniello P, Coumes-Marquet S, Agache P. Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties. Skin Pharmacol. 1992;5(2):108-13.
82. Shomaker TS, Zhang J, Ashburn MA. A pilot study assessing the impact of heat on the transdermal delivery of testosterone. J Clin Pharmacol. 2001;41(6):677-82.
83. Aly R, Shirley C, Cunico B, Maibach HI. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol. 1978;71(6):378-81.
84. Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology. 2009;255(1-2):33-7.
85. Gattu S, Maibach HI. Modest but increased penetration through damaged skin: an overview of the in vivo human model. Skin Pharmacol Physiol. 2011;24(1):2-9.
86. Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies V: permeation through damaged skin. J Pharm Sci. 1985;74(10):1062-6.
87. Hueber F, Besnard M, Schaefer H, Wepierre J. Percutaneous absorption of estradiol and progesterone in normal and appendage-free skin of the hairless rat: lack of importance of nutritional blood flow. Skin Pharmacol. 1994;7(5):245-56.
88. Hueber F, Wepierre J, Schaefer H. Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol. 1992;5(2):99-107.
89. Wester RC, Noonan PK, Maibach HI. Percutaneous absorption of hydrocortisone increases with longterm administration. In vivo studies in the rhesus monkey. Arch Dermatol. 1980;116(2):186-8.
90. Lu S, Xia D, Huang G, Jing H, Wang Y, Gu H. Concentration effect of gold nanoparticles on proliferation of keratinocytes. Colloids Surf B Biointerfaces. 2010;81(2):406-11.
91. Zhang LW, Monteiro-Riviere NA. Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol Physiol. 2008;21(3):166-80.
92. Zanette C, Pelin M, Crosera M, Adami G, Bovenzi M, Larese FF, et al. Silver nanoparticles exert a longlasting antiproliferative effect on human keratinocyte HaCaT cell line. Toxicol In Vitro. 2011;25(5): 1053-60.
93. Dunford R, Salinaro A, Cai L, Serpone N, Horikoshi S, Hidaka H, et al. Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Lett. 1997;418(1-2):87-90.
94. Shvedova AA, Castranova V, Kisin ER, Schwegler-Berry D, Murray AR, Gandelsman VZ, et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health. 2003;66(20):1909-26.
95. Menczel E, Maibach HI. In vitro human percutaneous penetration of benzyl alcohol and testosterone: epidermal-dermal retention. J Invest Dermatol. 1970;54(5):386-94.
96. Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm. 2005;288(2): 227-33.
97. Alikhan FS, Maibach H. Topical absorption and systemic toxicity. Cutan Ocul Toxicol. 2011;30(3): 175-86.
98. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006;3:11.
99. Wu J, Liu W, Xue C, Zhou S, Lan F, Bi L, et al. Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett. 2009;191(1):1-8.
100. Nadworny PL, Landry BK, Wang J, Tredget EE, Burrell RE. Does nanocrystalline silver have a transferable effect? Wound Repair Regen. 2010;18(2):254-65.
101. Yoshida D, Todo H, Hasegawa T, Sugibayashi K. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition. Int J Pharm. 2007;337(1-2):142-7.
102. Yoshida D, Todo H, Hasegawa T, Sugibayashi K. Effect of molecular weight on the dermatopharmacokinetics and systemic disposition of drugs after intracutaneous injection. Eur J Pharm Sci. 2008;35(1-2):5-11.
103. Yoshida D, Hasegawa T, Sugibayashi K. Targeting of salicylate to skin and muscle following topical injections in rats. Int J Pharm. 2002;231(2): 177-84.
104. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces. 2008;66(2):274-80.
105. Oberdorster G, Elder A, Rinderknecht A. Nanoparticles and the brain: cause for concern? J Nanosci Nanotechnol. 2009;9(8):4996-5007.
106. Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2010;245(1):116-23.
107. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem. 2004;15(1):79-86.
108. Lee HA, Imran M, Monteiro-Riviere NA, Colvin VL, Yu WW, Riviere JE. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett. 2007;7(9):2865-70.
109. King MJ, Michel D, Foldvari M. Evidence for lymphatic transport of insulin by topically applied biphasic vesicles. J Pharm Pharmacol. 2003;55(10): 1339-44.
110. Jakob T, Ring J, Udey MC. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol. 2001;108(5):688-96.
111. Igyarto BZ, Kaplan DH. The evolving function of Langerhans cells in adaptive skin immunity. Immunol Cell Biol. 2010;88(4):361-5.
112. Vogt A, Mahe B, Costagliola D, Bonduelle O, Hadam S, Schaefer G, et al. Transcutaneous antiin fluenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol. 2008;180(3):1482-9.
113. Lindwall G, Hsieh EA, Misell LM, Chai CM, Turner SM, Hellerstein MK. Heavy water labeling of keratin as a non-invasive biomarker of skin turnover in vivo in rodents and humans. J Invest Dermatol. 2006;126(4): 841-8.
114. Zheng Y, Vieille-Petit A, Chodoutaud S, Maibach HI. Dislodgeable stratum corneum exfoliation: role in percutaneous penetration? Cutan Ocul Toxicol. 2011;30(3):198-204.
115. Ossadnik M, Richter H, Teichmann A, Koch S, Schäfer U, Wepf R, et al. Investigation of differences in follicular penetration of particle-and nonoparticlecontaining emulsions by laser scanning microscopy. Laser Phys. 2006;16(5):747-50.
116. Hatch KL, Maibach HI. Textile chemicalfinish dermatitis. Contact Dermatitis. 1986;14(1):1-13.
117. Wester RC, Quan D, Maibach HI. In vitro percutaneous absorption of model compounds glyphosate and malathion from cotton fabric into and through human skin. Food Chem Toxicol. 1996;34(8):731-5.
118. Snodgrass HL. Permethrin transfer from treated cloth to the skin surface: potential for exposure in humans. J Toxicol Environ Health. 1992;35(2):91-105.
119. Wester RC, Hartway T, Serranzana S, Maibach HI. Human skin in vitro percutaneous absorption of gaseous ethylene oxide from fabric. Food Chem Toxicol. 1997;35(5):513-5.
120. Laughlin J. Decontaminating pesticide protective clothing. Rev Environ Contam Toxicol. 1993;130 :79-94.
121. Fitzgerald RH, Manley-Harris M. Laundering protocols for chlorpyrifos residue removal from pest control operators' overalls. Bull Environ Contam Toxicol. 2005;75(1):94-101.
122. Som C, Wick P, Krug H, Nowack B. Environmental and health effects of nanomaterials in nanotextiles and facade coatings. Environ Int. 2011;37(6): 1131-42.
123. Wester RC, Hui X, Landry T, Maibach HI. In vivo skin decontamination of methylene bisphenyl isocyanate (MDI): soap and water ineffective compared to polypropylene glycol, polyglycol-based cleanser, and corn oil. Toxicol Sci. 1999;48(1):1-4.
124. Zendzian RP. Pesticide residue on/in the washed skin and its potential contribution to dermal toxicity. J Appl Toxicol. 2003;23(2):121-36.
125. Bucks DA, Maibach HI, Guy RH. Percutaneous absorption of steroids: effect of repeated application. J Pharm Sci. 1985;74(12):1337-9.
126. Courtheoux S, Pechenot D, Bucks DA, Marty JP, Maibach HI, Wepierre J. Effect of repeated skin administration on in vivo percutaneous absorption of drugs. Br J Dermatol. 1986;115 Suppl 31:49-52.
127. Moody RP, Maibach HI. Skin decontamination: importance of the wash-in effect. Food Chem Toxicol. 2006;44(11):1783-8.
128. Ridout G, Hinz RS, Hostynek JJ, Reddy AK, Wiersema RJ, Hodson CD, et al. The effects of zwitterionic surfactants on skin barrier function. Fundam Appl Toxicol. 1991;16(1):41-50.
129. Fartasch M, Schnetz E, Diepgen TL. Characterization of detergent-induced barrier alterations-effect of barrier cream on irritation. J Investig Dermatol Symp Proc. 1998;3(2):121-7.
130. Marrakchi S, Maibach HI. Sodium lauryl sulfateinduced irritation in the human face: regional and age-related differences. Skin Pharmacol Physiol. 2006;19(3):177-80.
131. Kao J, Carver MP. Cutaneous metabolism of xenobiotics. Drug Metab Rev. 1990;22(4):363-410.
132. Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R. Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev. 2007; 39(4):659-98.
133. Kao J, Patterson FK, Hall J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol Appl Pharmacol. 1985;81(3 Pt 1):502-16.
134. Hikima T, Maibach HI. Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro. Skin Pharmacol Physiol. 2007;20(4):168-74.
135. Bando H, Mohri S, Yamashita F, Takakura Y, Hashida M. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharm Sci. 1997;86(6):759-61.
136. Kao J, Hall J, Shugart LR, Holland JM. An in vitro approach to studying cutaneous metabolism and disposition of topically applied xenobiotics. Toxicol Appl Pharmacol. 1984;75(2):289-98.
137. Bronaugh RL, Stewart RF, Storm JE. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol Appl Pharmacol. 1989;99(3): 534-43.
138. Kao J, Hall J. Skin absorption and cutaneousfirst pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture. J Pharmacol Exp Ther. 1987;241(2):482-7.
139. Bronaugh RL. Methods for in vitro skin metabolism studies. In: Zhai H, Wilhelm KP, Maibach HI, editors. Marzulli and Maibach's dermatotoxicology. 7th ed. Boca Raton: CRC Press; 2008. p. 373-6.
140. Jewell C, Heylings J, Clowes HM, Williams FM. Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro. Arch Toxicol. 2000;74(7): 356-65.
141. Popov AP, Zvyagin AV, Lademann J, Roberts MS, Sanchez W, Priezzhev AV, et al. Designing inorganic light-protective skin nanotechnology products. J Biomed Nanotechnol. 2010;6(5):432-51.
142. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett. 2008;8(9):2779-87.
143. Marzulli FN, Maibach HI. Relevance of animal models\-The hexachlorophene story. In: Maibach HI, editor. Animal models in dermatology. Edinburgh: Churchill Living Stone; 1975. p. 156-67.
144. Nigg HN, Stamper JH. Biological monitoring for pesticide dose determination. In: Wang RGM, Franklin CA, Honeycutt RC, Reinert JC, editors. Biological monitoring for pesticide exposure: measurement, estimation, and risk reduction. Washington, DC: American Chemical Society; 1989. p. 6-27.
145. Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect. 2007;115(9):1339-43.
146. Yeh TK, Wu JP, Chang LW, Tsai MH, Chang WH, Tsai HT, et al. Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: safety implications and applications. Nanotoxicology. 2011;5(1):91-7.
147. Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine. 2009;5(2):162-9.
148. Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007; 20(1):10-20.
149. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol. 2005;125(2):264-9.
150. Bronaugh RL, Maibach HI, editors. Percutaneous absorption: drugs, cosmetics, mechanisms, methodology. 4th ed. New York: Marcel Dekker; 2005.
151. Gilman SD, Gee SJ, Hammock BD, Vogel JS, Haack K, Buchholz BA, et al. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine. Anal Chem. 1998;70(16): 3463-9.
152. Blume-Peytavi U, Vogt A. Human hair follicle: reservoir function and selective targeting. Br J Dermatol. 2011;165 Suppl 2:13-7.
153. Lademann J, Knorr F, Richter H, Blume-Peytavi U, Vogt A, Antoniou C, et al. Hair follicles-an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charite-Universitatsmedizin Berlin, Germany. Skin Pharmacol Physiol. 2008;21(3):150-5.
154. Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route-research progress and future perspectives. Eur J Pharm Biopharm. 2009;71(2):173-80.
155. OECD (2004) Guidelines for the testing of chemicals: test no. 427: skin absorption: in vivo method. Paris: Organisation for Economic Co-operation and Development.
156. Feldmann RJ, Maibach HI. Percutaneous penetration of steroids in man. J Invest Dermatol. 1969;52(1): 89-94.
157. Maibach HI, Wester RC. Percutaneous absorption: in vivo methods in humans and animals. J Am Coll Toxicol. 1989;8(5):803-13.
158. Bronaugh RL, Wester RC, Bucks D, Maibach HI, Sarason R. In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans. Food Chem Toxicol. 1990;28(5):369-73.
159. Wester RC, Maibach HI. In vivo animal models for percutaneous absorption. In: Bronaugh R, Maibach H, editors. Percutaneous absorption. New York: Marcel Dekker; 1985. p. 251-66.
160. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett. 2007;171(3):99-110.
161. Ema M, Matsuda A, Kobayashi N, Naya M, Nakanishi J. Evaluation of dermal and eye irritation and skin sensitization due to carbon nanotubes. Regul Toxicol Pharmacol. 2011;61(3):276-81.
162. Tregear RT. Physical properties of the skin. New York: Academic; 1966.
163. Crutcher W, Maibach HI. The effect of perfusion rate on in vitro percutaneous penetration. J Invest Dermatol. 1969;53(4):264-9.
164. Chang SK, Brownie C, Riviere JE. Percutaneous absorption of topical parathion through porcine skin: in vitro studies on the effect of environmental perturbations. J Vet Pharmacol Ther. 1994;17(6):434-9.
165. Chang SK, Riviere JE. Percutaneous absorption of parathion in vitro in porcine skin: effects of dose, temperature, humidity, and perfusate composition on absorptive flux. Fundam Appl Toxicol. 1991;17(3): 494-504.
166. Reifenrath WG, Hawkins GS, Kurtz MS. Percutaneous penetration and skin retention of topically applied compounds: an in vitro-in vivo study. J Pharm Sci. 1991;80(6):526-32.
167. van de Sandt JJ, van Burgsteden JA, Cage S, Carmichael PL, Dick I, Kenyon S, et al. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol. 2004;39(3):271-81.
168. Behl CR, Barrett M. Hydration and percutaneous absorption II: in fluence of hydration on water and alkanol permeation through Swiss mouse skin; comparison with hairless mouse. J Pharm Sci. 1981;70(11):1212-5.
169. Behl CR, El-Sayed AA, Flynn GL. Hydration and percutaneous absorption IV: in fluence of hydration on n-alkanol permeation through rat skin; comparison with hairless and Swiss mice. J Pharm Sci. 1983;72(1):79-82.
170. Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI, et al. Hydration and percutaneous absorption: I. In fluence of hydration on alkanol permeation through hairless mouse skin. J Invest Dermatol. 1980;75(4):346-52.
171. Moss GP, Dearden JC, Patel H, Cronin MT. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitro. 2002;16(3):299-317.
172. Frasch HF, Barbero AM, Hettick JM, Nitsche JM. Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin. J Pharm Sci. 2011;100(7): 2989-95.
173. Anissimov YG, Roberts MS. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics. J Pharm Sci. 2009;98(2):772-81.
174. Aschberger K, Micheletti C, Sokull-Kluttgen B, Christensen FM. Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health-lessons learned from four case studies. Environ Int. 2011;37(6):1143-56.